Vectormune FP ILT

País: União Europeia

Língua: dinamarquês

Origem: EMA (European Medicines Agency)

Ingredientes ativos:

recombinant fowlpox virus expressing the membrane fusion protein and the encapsidation protein of avian infectious laryngotracheitis virus, live

Disponível em:

CEVA-Phylaxia Co. Ltd.

DCI (Denominação Comum Internacional):

Fowlpox and avian infectious laryngotracheitis vaccine (live, recombinant)

Grupo terapêutico:

Kylling

Indicações terapêuticas:

For active immunisation of chickens from 8 weeks of age in order to reduce the skin lesions due to fowlpox and to reduce the clinical signs and tracheal lesions due to avian infectious laryngotracheitis.

Status de autorização:

autoriseret

Data de autorização:

2020-12-09

Folheto informativo - Bula

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Opdateret information om dette lægemiddel til dyr er tilgængelig på
webstedet for information om
lægemidler til dyr.

Características técnicas

OFFICIAL ADDRESS
Domenico Scarlattilaan 6
●
1083 HS Amsterdam
●
The Netherlands
An agency of the European Union
ADDRESS FOR VISITS AND DELIVERIES
Refer to www.ema.europa.eu/how-to-find-us
SEND US A QUESTION
Go to
www.ema.europa.eu/contact
TELEPHONE
[phone]
6000
© European Medicines Agency,
2023. Reproduction is authorised provided the source is acknowledged.
Opdateret information om dette lægemiddel til dyr er tilgængelig på
webstedet for information om
lægemidler til dyr.